National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

remifentanil hydrochloride
The hydrochloride salt form of remifentanil, a synthetic anilidopiperidine derivative and short-acting opiate agonist with analgesic and anesthetic properties. Remifentanil selectively binds to and activates the mu-opioid receptor, thereby producing analgesia, respiratory depression, miosis, reduced gastrointestinal motility, and euphoria. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Ultiva
Chemical structure name:1-Piperidinepropanoic Acid, 4-(methoxycarbonyl)-4-((1-oxopropyl)phenylamino)-, Methyl Ester, Monohydrochloride



Previous:Regitine, Reglan, Remeron, Remicade, Remifemin
Next:Remitogen, renal cell carcinoma peptides vaccine IMA901, renal cell carcinoma/CD40L RNA-transfected autologous dendritic cell vaccine AGS-003, Rencarex, Renova

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov